Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

Tekijä Stüve, O, Cravens, P D., Frohman, E M., Phillips, J T., Remington, G M., von Geldern, G, Cepok, S, Singh, M P., Cohen Tervaert, J W., De Baets, M, MacManus, D, Miller, D H., Radü, E W., Cameron, E M., Monson, N L., Zhang, S, Kim, R, Hemmer, B, Racke, M K.
Julkaistu 2009